Effect of Tadalafil Once a Day in Men With Erectile Dysfunction
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to assess the efficacy and safety of tadalafil 5 mg
administered once a day in patients with erectile dysfunction (ED) who are naïve to PDE5
(phosphodiesterase type 5) inhibitors. Patients may be dose reduced to 2.5mg based on
tolerability.